p38MAPK-Activated AKT in HER-2 Overexpressing Human Breast Cancer Cells Acts as an EGF-Independent Survival Signal

Journal of Surgical Research

Volumn 142, Issue 1, 2007, Pages 162-169

  Diehl, Kathleen M ^a   Grewal, Navdeep ^a   Ethier, Stephen P ^b   Woods Ignatoski, Kathleen M ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

AKT; EGF; growth factor independence; HER 2; p38MAPK; survival

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INVASION; CELL MOTILITY; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION;

EID: 34547928128     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.01.025     Document Type: Article

References (41)

1. Kraus M., Popescu N., Amsbaugh S., et al. Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6 (1987) 605
2. Lacroix H., Iglehart J.D., Skinner M.A., et al. Overexpression of erbB-2 or EGF receptor proteins present in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases # 147. Oncogene 4 (1989) 145
3. Slamon D.J., Clark G.M., Wong S.G., et al. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235 (1987) 177
4. McKenzie S.J. Diagnostic utility of oncogenes and their products in human cancer. Biochim Biophys Acta 1072 (1991) 193
5. Woods-Ignatoski K.M., LaPointe A.J., Radany E.H., et al. erbB-2 overexpression in human mammary epithelial cells confers growth factor independence. Endocrinology 140 (1999) 3615
6. Woods-Ignatoski K.M., Maehama T., Markwart S.M., et al. erbB-2 overexpression confers PI 3′-kinase-dependent invasion capacity on human mammary epithelial cells. Br J Cancer 82 (2000) 666
7. Woods-Ignatoski K.M., Livant D.L., Grewal N.K., et al. p38MAPK induces cell surface a4 integrin down-regulation to facilitate erbB-2-mediated invasion. Neoplasia 5 (2003) 128
8. Woods-Ignatoski K.M., Livant D.L., Markwart S., et al. The role of PI3′kinase and its downstream signals in erbB-2-mediated transformation. Mol Cancer Res 1 (2003) 551
9. Burgering B.M.T., and Coffer P.J. Protein kinase B (c-ACT) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376 (1995) 599
10. Datta K., Bellacosa A., Chan T.O., et al. ACT is a direct target of the phosphatidylinositol 3-kinase. J Biol Chem 271 (1996) 30835
11. Toker A., and Yoeli-Lerner M. ACT signaling and cancer: Surviving but not moving on. Cancer Res 66 (2006) 3963
12. Cheatham B., Vlahos C.J., Cheatham L., et al. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol 14 (1994) 4902
13. Datta S.R., Dudek H., Tao X., et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91 (1997) 231
14. Kolanus W., and Seed B. Integrins and inside-out signal transduction: Converging signals from PKC and PIP3. Curr Opin Cell Biol 9 (1997) 725
15. Cockcroft S. Mammalian phosphatidylinositol transfer proteins: Emerging roles in signal transduction and vesicular traffic. Chem Phys Lipids 98 (1999) 23
16. Yoeli-Lerner M., and Toker A. ACT/PKB signaling in cancer: A function in cell motility and invasion. Cell Cycle 5 (2006) 603
17. Kennedy S.G., Wagner A.J., Conzen S.D., et al. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev 11 (1997) 701
18. Toker A., and Cantley L.C. Signaling through the lipid products of phosphoinositide-3-OH kinase. Nature 387 (1997) 673
19. Bose S., Chandran S., Mirocha J.M., et al. The ACT pathway in human breast cancer: A tissue-array-based analysis. Mod Pathol 19 (2006) 238
20. Tokunaga E., Kataoka A., Kimura Y., et al. The association between ACT activation and resistance to hormone therapy in metastatic breast cancer. Eur J Cancer 42 (2006) 629
21. Woods-Ignatoski K.M., Dziubinski M.L., Ammerman C.A., et al. Cooperative interactions of HER-2 and HPV-16 oncoproteins in the malignant transformation of human mammary epithelial cells. Neoplasia 7 (2005) 788
22. Woods-Ignatoski K., and Ethier S.P. Constitutive activation of pp125fak in eleven newly isolated breast cancer cell lines. Breast Cancer Res Treat 54 (1999) 173
23. Rane M.J., Coxon P.Y., Powell D.W., et al. p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for ACT in human neutrophils. J Biol Chem 276 (2001) 3517
24. Carlson C.A., and Ethier S.P. Lack of RB protein correlates with increased sensitivity to UV radiation-induced apoptosis in human breast cancer cells. Radiat Res 154 (2000) 590
25. Ethier S.P., Ammerman C.A., and Dziubinski M.L. Isolation and culture of human breast cancer cells from primary tumors and metastases. In: Ip M.M., and Asch B.B. (Eds). Methods in Mammary Gland Biology and Breast Cancer (2000), Kluwer Academic/Plenum Publishers, New York 195
26. Rao G.S., Murray S., and Ethier S.P. Radiosensitization of human breast cancer cells by a novel erbB family receptor tyrosine kinase inhibitor. Int J Radiat Oncol Biol Phys 48 (2000) 1519
27. Berquin I.M., Dziubinski M.L., Nolan G.P., et al. A functional screen for genes inducing epidermal growth factor autonomy of human mammary epithelial cells confirms the role of amphiregulin. Oncogene 20 (2001) 4019
28. Ethier S.P. Identifying and validating causal genetic alterations in human breast cancer. Breast Cancer Res Treat 78 (2003) 285
29. Kumar-Sinha C., Woods-Ignatoski K., Lippman M.E., et al. Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res 63 (2003) 132
30. Ray M.E., Yang Z.Q., Albertson D., et al. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res 64 (2004) 40
31. Woods-Ignatoski K.M., Diehl K.M., and Ethier S.P. Independent and cooperative roles of over-expressed erbB-2 in transformation of human mammary epithelial cells. Proc Am Assoc Cancer Res 45 (2004) 3503
32. Klutchko S.R., Zhou H., Winters R.T., et al. Tyrosine kinase inhibitors. 19. 6-Alkynamides of 4-anilinoquinazolines and 4-anilinopyrido[3,4-d]pyrimidines as irreversible inhibitors of the erbB family of tyrosine kinase receptors. J Med Chem 49 (2006) 1475
33. Maehama T., and Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273 (1998) 13375
34. Nicolle G., Daher A., Maillé P., et al. Gefitinib inhibits the growth and invasion of urothelial carcinoma cell lines in which ACT and MAPK activation is dependent on constitutive epidermal growth factor receptor activation. Clin Cancer Res 12 (2006) 2937
35. Hutchinson J., Jin J., Cardiff R.D., et al. Activation of ACT (protein kinase B) in mammary epithelium provides a critical cell survival signal required for tumor progression. Mol Cell Biol 21 (2001) 2203
36. Debnath J., Mills K.R., Collins N.L., et al. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111 (2002) 29
37. Debnath J., Muthuswamy S.K., and Brugge J.S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30 (2003) 256
38. Debnath J., Walker S.J., and Brugge J.S. ACT activation disrupts mammary acinar architecture and enhances proliferation in an mTorr-dependent manner. J Cell Biol 163 (2003) 315
39. Irie H.Y., Pearline R.V., Grueneberg D., et al. Distinct roles of AKT1 and AKT2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 17 (2005) 1023
40. App H., Hazan R., Zilberstein A., et al. Epidermal growth factor (EGF) stimulates association and kinase activity of Raf-1 with the EGF Receptor # 363. Mol Cell Biol 11 (1991) 913
41. She Q.B., Solit D.B., Ye Q., et al. The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/AKT kinase pathways in PTEN-deficient tumor cells. Cancer Cell 8 (2005) 287